Literature DB >> 8856250

Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.

J A Jakobsen1, K J Berg, P Kjaersgaard, F Kolmannskog, K P Nordal, J O Nossen, K Rootwelt.   

Abstract

The effects of contrast media on renal function and the cortical retention of contrast media after abdominal angiography were investigated. Sixteen nondiabetic patients with predialytic chronic renal failure received either the nonionic dimeric contrast medium iodixanol or the monomeric contrast medium iohexol in a double-blind randomized study. All patients were well hydrated before, during and after angiography. Mean 99mTc-DTPA clearance was 14.0 ml/min/1.73 m2 in the iodixanol group, and 9.3 ml/min/1.73 m2 in the iohexol group at baseline. No statistically significant changes were seen after angiography. Serum creatinine increased significantly 48 and 72 h after angiography in both groups, and then normalized. Creatinine clearance was reduced only in the iohexol group, at 72-96 h. The urinary excretion of renal enzymes and of total protein did not change significantly. No patients developed oliguria or required dialysis during the 7-day observation period. Increased attenuation in the renal cortex, measured by computed tomography and probably reflecting intracellular retention of contrast medium, peaked at 24 h, and was observed in both groups during the follow-up period. Thus, although transient and minor changes in glomerular filtration rate were noted, both iodixanol and iohexol were safe for use in angiography in nondiabetic patients with severe chronic failure when the patients were well hydrated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856250     DOI: 10.1159/000189139

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis.

Authors:  Peter A McCullough; Jeremiah R Brown
Journal:  Cardiorenal Med       Date:  2011-10-04       Impact factor: 2.041

2.  Renal experience with Visipaque.

Authors:  J A Jakobsen
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.

Authors:  Shinn-Huey Chou; Zhen J Wang; Jonathan Kuo; Miguel Cabarrus; Yanjun Fu; Rizwan Aslam; Judy Yee; Jeffrey M Zimmet; Kendrick Shunk; Brett Elicker; Benjamin M Yeh
Journal:  Eur J Radiol       Date:  2011-04-05       Impact factor: 3.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.